{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:18:03Z","timestamp":1778811483983,"version":"3.51.4"},"reference-count":73,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"unspecified","delay-in-days":604,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2019,10,3]]},"DOI":"10.1080\/21645515.2019.1634992","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T13:50:30Z","timestamp":1562161830000},"page":"2258-2263","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-7946","authenticated-orcid":false,"given":"Christine C.","family":"Roberts","sequence":"first","affiliation":[{"name":"Clinical Laboratory Development, GeneOne Life Science, Inc., Blue Bell, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"key":"cit0001","unstructured":"WHO. R&D Blueprint 2018 List of priority diseases. [accessed 2018 Sep 06]. https:\/\/www.who.int\/blueprint\/priority-diseases\/en\/."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.094"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis238"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7462"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/npjvaccines.2016.21"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15743"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708120"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2018.03.001"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1358325"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3201\/eid2502.180798"},{"key":"cit0011","volume-title":"Organization manual for the preparation of secondary reference materials for in vitro diagnostic assays designed for infectious disease nucleic acid or antigen detection: calibration to WHO International Standards","author":"WHO. World Health"},{"key":"cit0012","unstructured":"WHO. Collaborative study to evaluate a candidate world health organization international standard for zika virus for nucleic acid amplification technique (NAT)-based assays. 2016 [accessed 2019 Apr 03]. http:\/\/www.who.int\/iris\/handle\/10665\/253051."},{"key":"cit0013","unstructured":"FDA provides new tools for the development and proper evaluation of tests for detecting Zika virus infection, <https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm572197.htm> (2017)."},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.102"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-017-0232-7"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-018-0153-7"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1515\/jomb-2017-0029"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0107"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6939-12-5"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6939-14-35"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6939-15-76"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-015-0077-x"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-015-0047-3"},{"key":"cit0024","volume-title":"Coalition for Epidemic Preparedness Innovations","author":"CEPI"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.04.10"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.02.021"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1021\/pr500475q"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.2.5261"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1038\/srep17925"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1039\/c5lc00398a"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-017-0517-y"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.01.008"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.3390\/v10050253"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29205"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2016.03.001"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.016"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3389-1_51"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-1-199701010-00026"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.05.022"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.03.006"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005269"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0091"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01785-17"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1067-x"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8727-1_3"},{"key":"cit0046","unstructured":"FDA. Current emergency use authorizations.\u00a02019 [accessed 2019 Apr 03]. https:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/MCMLegalRegulatoryandPolicyFramework\/ucm182568.htm#current."},{"key":"cit0047","unstructured":"FDA. Zika emergency use authorizations. [accessed 2018 Sep 06]. https:\/\/www.fda.gov\/medicaldevices\/safety\/emergencysituations\/ucm161496.htm#zika."},{"key":"cit0048","unstructured":"WHO. World Health Organization emergency use and listings procedures. \u00a0[accessed 2018 Sep 06]. http:\/\/www.who.int\/medicines\/news\/public_consult_med_prods\/en\/."},{"key":"cit0049","unstructured":"FDA zika virus diagnostic development. [accessed 2018 Sep 21]. https:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/MCMIssues\/ucm494615.htm#pport."},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.41.30042"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.16.175950"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-311"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.16.30203"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02153-16"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.50.30426"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.3201\/eid2207.160326"},{"key":"cit0057","unstructured":"FDA zika EUA Table1 molecular assay performance characteristics. [accessed 2018 Sep 21]. https:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/EmergencySituations\/UCM606289.pdf."},{"key":"cit0058","unstructured":"FDA zika eua table 2 summary molecular assay characteristics. [accessed 2018 Sep 06]. https:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/EmergencySituations\/UCM606290.pdf."},{"key":"cit0059","unstructured":"CDC zika testing guidance for healthcare providers. [accessed 2018 Sep 21]. https:\/\/www.cdc.gov\/zika\/hc-providers\/testing-guidance.html."},{"key":"cit0060","unstructured":"CDC U Interpretation of Nucleic Acid and Immunoassay test results for suspected Zika Infection. 2017 [accessed 2018 Sep 06]. https:\/\/www.cdc.gov\/zika\/laboratories\/lab-guidance.html#table1."},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1306615"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1412024"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00074-09"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.16.171207"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00509"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2016.07.017"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004655"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00279-16"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjtm.2016.01.016"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.23874"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02677"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.3201\/eid2207.160022"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31224-2"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1634992","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1634992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T02:36:59Z","timestamp":1620614219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1634992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,3]]}},"alternative-id":["10.1080\/21645515.2019.1634992"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1634992","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}